Photocure to Exit Allumera Business
Oslo, Norway, 1 October 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today that it has made the strategic decision to exit its Allumera[®] cosmetic dermatology business in the US. Allumera was in a highly competitive market and despite the product being supported by an experienced dedicated dermatology team, it has not delivered the growth potential that Photocure had expected. Photocure intends to support current Allumera customers through a customer service center for the remainder of the